Bio-Rad Laboratories (BIO) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Bio-Rad Laboratories (BIO) Company Statistics | The Fly

Bio-Rad Laboratories

· BIO

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

10.185 B

-0.48%

General

Market Cap: $10.18B
Enterprise Value: $10.85B
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 51.90%
Operating Margin: 9.08%
Net Profit Margin: 8.59%
FCF Margin: 13.64%
ROA: 2.17%
ROE: 3.15%
ROIC: 1.54%
Current Ratio: 3.14
Debt-to-Equity: 0.17
Revenue Per Employee: —

Valuation (TTM)

P/E: 45.42
PEG: —
P/S: 3.93
P/FCF: 28.79
P/B: 1.42
EV/EBITDA: 20.30

Growth

Rev 1Y: 0.65%

Income Statement (TTM)

Revenue: $2.59B
Gross Margin: 51.90%
Operating Expenses: $1.11B
Operating Income: $235M
Net Profit: $222.4M

Balance Sheet

Rev 1Y Fwd Est

-0.07%

Rev 3Y (CAGR)

-2.68%

Rev 5Y (CAGR)

0.29%

Rev 10Y (CAGR)

2.49%

EPS 1Y

—

EPS 1Y Fwd Est

-65.21%

EPS 3Y (CAGR)

—

EPS 5Y (CAGR)

-26.07%

EPS 10Y (CAGR)

22.34%

Cash and Equivalents: $517M
Working Capital: $2.06B
Total Assets: $10.25B
Net Debt: $686.7M
Total Liabilities: $3.08B
Total Equity: $7.17B

Cash Flow Statement (TTM)

Cash Flow from Operations: $492.6M
Cash Flow from Investing: -$237.1M
Cash Flow from Financing: -$121.1M
Free Cash Flow: $353.1M
Capital Expenditures: $139.5M